Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jan;8(1):19-25.
doi: 10.1136/flgastro-2015-100670. Epub 2016 Jul 19.

Gastrointestinal stromal tumours (GISTs): an insight into clinical practice with review of literature

M J McDonnell  1 , S Punnoose  1 , Y K S Viswanath  1 , N J Wadd  1 , A Dhar  1
Affiliations

Gastrointestinal stromal tumours (GISTs): an insight into clinical practice with review of literature

M J McDonnell et al. Frontline Gastroenterol. 2017 Jan.

Abstract

Background: Gastrointestinal stromal tumours (GISTs) are rare mesenchymal tumours of the gastrointestinal tract. We retrospectively reviewed the clinical management of all patients with GIST presenting to a regional multidisciplinary upper gastrointestinal cancer group in the north of England.

Methods: Clinical, pathological, immunohistochemical treatment strategies, follow-up and outcome data on all patients with GIST between 2007 and 2012 were reviewed. Tumours were categorised by risk according to the National Institutes of Health (NIH) and AFIP models.

Results: 36 (85.7%) of 42 tumours were located in the stomach, 5 (11.9%) in the small intestine and 1 (2.4%) in the oesophagus. Median age of patients was 68 (range 43-91) years. 24 patients (57.1%) were female. Tumour size ranged from 1.0 to 12.7 cm with mean size of 5.46 cm. Metastasis was present in 19 (45.2%) patients at diagnosis with distant metastases in 12 patients. Liver was the most common site of metastases. Histology and immunohistochemical analysis was available in 32 (76.2%) patients. Most common histology was spindle cell morphology 17/32 (53.1%) followed by epithelioid 9/32 (28.1%) and mixed morphology 5/32 (15.6%). The positive rate for KIT protein (CD117) was 90.6%, while that for CD34 was 75.0%. 12/25 (48.0%) and 8/23 (34.8%) patients were categorised as high risk as per NIH and AFIP risk scores, respectively. 23/42 (54.8%) patients underwent surgical resection, after which 5/23 (21.7%) had adjuvant imatinib therapy. Imatinib was given as primary therapy in 14/42 (33.3%) patients.

Conclusions: Surgery alone may not be a curative treatment for GISTs. Targeted therapy with imatinib may play an important role in the treatment of GISTs. Further risk categorisation models may be needed to evaluate GIST behaviour and prognosis.

Keywords: GASTRIC NEOPLASIA; GASTROINTESTINAL CANCER.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Overall survival.
See this image and copyright information in PMC

References

    1. Rossi CR, Mocellin S, Mancarelli R, et al. . Gastrointestinal stromal tumours: from a surgical to a molecular approach. Int J Cancer 2003;107:171–6. doi:10.1002/ijc.11374 - DOI - PubMed
    1. Burkill GJ, Badran M, Al-Muderis O, et al. . Malignant gastrointestinal stromal tumour: distribution, imaging features and patterns of metastatic spread. Radiology 2003;226:527–32. doi:10.1148/radiol.2262011880 - DOI - PubMed
    1. Rubin BP. Gastrointestinal stromal tumours: an update. Histopathology 2006;48:83–96. doi:10.1111/j.1365-2559.2005.02291.x - DOI - PubMed
    1. Singhal T, Doddi S, Leake T, et al. . Upper gastrointestinal bleeding due to gastric stromal tumour: a case report. Cases J 2010;3:58 doi:10.1186/1757-1626-3-58 - DOI - PMC - PubMed
    1. Benesch M, Wardelmann E, Ferrari A, et al. . Gastrointestinal stromal tumours (GIST) in children and adolescents: a comprehensive review of the current literature. Paediatric Blood Cancer 2009:53:1171–79. doi:10.1002/pbc.22123 - DOI - PubMed

LinkOut - more resources